Cancer Institute A national cancer institute
designated cancer center

Immunotherapy of Cancer Research Progrm

The newly formed Immunotherapy of Cancer Program brings together the basic science and clinical translational strengths of the prior Programs to provide further opportunities for synergy and collaboration and we believe a stronger Program than either Program alone. The development of exciting and comprehensive tools for analysis of immune responses including CyTOF and high throughput sequencing as well as novel immunological therapeutic interventions provide many new opportunities.  This change was presented to our External Scientific Advisory Committee who enthusiastically supported the merger of these two Programs. The goals of the new Program are:

Immunotherapy of Cancer Program Membership Roster

Program Directors

Robert Negrin, MD

Edgar Engleman, MD

 

Stanford Medicine Resources:

Footer Links: